Company Analysis
Sign in

abrdn Life Sciences Investors (HQL)

NYSE: HQL · filing with the SEC since 1995
Full chart Alerts Compare
Grade4.6
◀ Past 4.3● Present 4.5▶ Future 5.0
8 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyas filed
Revenuen/a
Net incomen/a
Earnings per sharen/a
Operating cash flown/a
Cashn/a
Debtn/a
Shareholders’ equityn/a
Shares, dilutedn/a
Return on equityn/a
The recordfrom its filings
Filings in 202614
Newest filingOct 14 · SCHEDULE 13G/A
Annual reportn/a
Quarterly reportn/a
Next report due10-Q by Feb 14
Insider sales, 12 months$0.00
Insider buys, 12 months$100,000
Patents grantedn/a
Filer categoryn/a
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
The record holds no annual figures yet.
As filed, in USD. Nothing here is a forecast.

News

Sep 24, 2026 · SEC EDGAR · Form 40-17G
Form 40-17G
Open the filing on sec.gov
Aug 28, 2026 · SEC EDGAR · Form NPORT-P
Form NPORT-P
Open the filing on sec.gov
Aug 21, 2026 · SEC EDGAR · Form N-PX
Proxy voting record
Open the filing on sec.gov
Jul 20, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Jun 8, 2026 · SEC EDGAR · Form N-CSRS
Form N-CSRS
Open the filing on sec.gov
May 29, 2026 · SEC EDGAR · Form NPORT-P
Form NPORT-P
Open the filing on sec.gov
Apr 7, 2026 · SEC EDGAR · Form DEF 14A
Proxy statement
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton HQL · research, not advice